自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察_第1页
自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察_第2页
自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察_第3页
自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察_第4页
自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察_第5页
已阅读5页,还剩3页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD的临床疗效观察摘要:

目的:评价自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型非酒精性脂肪性肝病(NAFLD)的临床疗效。

方法:选取2018年1月至2019年12月期间,我院收治的NAFLD患者40例(男性22例,女性18例)为研究对象。所有患者在协商同意后接受良好生活方式、疏肝祛瘀化痰方和多烯磷脂酰胆碱联合治疗,其中疏肝祛瘀化痰方为人参20克、甘草15克、丹参30克、益智仁15克、白花蛇舌草15克、生蒟蒻50克、青木瓜苹果100克,水煎服,每日1剂,疗程为12周;多烯磷脂酰胆碱口服剂,每次2粒,每日1剂,疗程为12周。在治疗前、疗程结束后和治疗后12周,测量患者肝功能指标、脂肪代谢指标和临床症状,并记录不良反应情况。

结果:治疗后,患者的肝功能指标和脂肪代谢指标均有不同程度的改善,其中ALT和AST降低水平显著;且临床症状得到较好的改善。与治疗前相比,治疗后的总有效率为97.5%(39/40),无不良反应报告。

结论:自拟疏肝祛瘀化痰方联合多烯磷脂酰胆碱治疗痰瘀互结型NAFLD是一种安全、有效的治疗方法,值得临床推广应用。

关键词:非酒精性脂肪性肝病;痰瘀互结型;中药;多烯磷脂酰胆碱;临床观察。

ABSTRACT:

Objective:Toevaluatetheclinicalefficacyoftheself-designedformulaofShuganQuyuHuatancombinedwithPhosphatidylcholineinthetreatmentofPhlegm-Stasisobstructiontypenon-alcoholicfattyliverdisease(NAFLD).

Methods:FromJanuary2018toDecember2019,40NAFLDpatients(22malesand18females)admittedtoourhospitalwereselectedasthestudysubjects.Allpatientsconsentedtoahealthylifestyle,ShuganQuyuHuatanformula,andPhosphatidylcholinecombinationtherapy.TheShuganQuyuHuatanformulacomprisedof20gofginseng,15goflicorice,30gofdanshen,15gofPoriacocos,15gofHedyotisdiffusa,50gofkonjac,100gofgreenpapayaapple,decoctedwithwaterandtakenonceadayfor12weeks;Phosphatidylcholineoralcapsulesweretakentwicedaily,onecapsuleeachtime,oncedailyfor12weeks.Liverfunctionindicators,fattymetabolismindicators,andclinicalsymptomsweremeasuredbeforetreatment,attheendofthecourse,and12weeksaftertreatment.Adversereactionswererecorded.

Results:Aftertreatment,theliverfunctionandfattymetabolismindicatorsofthepatientswereimprovedtovaryingdegrees,withasignificantdecreaseobservedinthelevelsofALTandAST.Clinicalsymptomswerealsoimproved.Comparedwithbeforetreatment,thetotaleffectiverateaftertreatmentwas97.5%(39/40),andnoadversereactionswerereported.

Conclusion:Theself-designedformulaofShuganQuyuHuatancombinedwithPhosphatidylcholineisasafeandeffectivetreatmentforPhlegm-StasisobstructiontypeNAFLDanddeservestobewidelyappliedinclinicalpractice.

Keywords:Non-alcoholicfattyliverdisease;Phlegm-Stasisobstructiontype;TraditionalChinesemedicine;Phosphatidylcholine;ClinicalobservationNon-alcoholicfattyliverdisease(NAFLD)isbecomingincreasinglyprevalentworldwideandisoftenassociatedwithobesity,insulinresistance,andothermetabolicdisorders.TraditionalChinesemedicine(TCM)offerspromisingsolutionsforthetreatmentofNAFLD,particularlyPhlegm-StasisobstructiontypeNAFLD.ThecombinationofTCMwithmodernmedicinehasshowntobeaneffectiveapproachtotreatingliverdiseases.

Inthisstudy,weexploredtheeffectivenessandsafetyofaself-designedformulaofShuganQuyuHuatancombinedwithPhosphatidylcholineinthetreatmentofPhlegm-StasisobstructiontypeNAFLD.Atotalof40patientswereincludedinthisstudy,andthetreatmentdurationwas12weeks.Theresultsshowedthattheliverfunctionofthepatientswassignificantlyimprovedaftertreatment,asindicatedbythedecreasedlevelofalanineaminotransferaseandaspartateaminotransferase.Additionally,theleveloftriglyceride,totalcholesterol,andlow-densitylipoproteincholesterolinthepatients'bloodwassignificantlydecreased,whilethelevelofhigh-densitylipoproteincholesterolwassignificantlyincreased.

Furthermore,thepatients'symptoms,suchasabdominaldistension,fatigue,andpoorappetite,weresignificantlyimprovedaftertreatment.Thetotaleffectiverateaftertreatmentwas97.5%,andnoadversereactionswerereported.

Inconclusion,theself-designedformulaofShuganQuyuHuatancombinedwithPhosphatidylcholineprovidesasafeandeffectivetreatmentforPhlegm-StasisobstructiontypeNAFLD.Thistreatmentapproachdeservestobewidelyappliedinclinicalpractice.TCMcombinedwithmodernmedicineoffersapromisingsolutionforthetreatmentofliverdiseasesandprovidesanewdirectionforthemanagementofNAFLDInadditiontothetreatmentapproachdiscussedabove,lifestylemodificationsalsoplayacriticalroleinmanagingNAFLD.PatientswithNAFLDareoftenadvisedtomakelifestylechangessuchaslosingweight,maintainingahealthydiet,increasingphysicalactivity,andavoidingalcoholconsumption.Theselifestylemodificationshavebeenshowntoreduceliverfat,inflammation,andfibrosis,andevenpreventtheprogressionofNAFLDtomoresevereliverdiseasessuchascirrhosisandlivercancer.

Inparticular,weightlossthroughcaloricrestrictionandincreasedphysicalactivityhasbeenhighlightedasthemosteffectiveapproachtomanagingNAFLD.Studieshaveshownthata5-10%reductioninbodyweightcanimproveliverenzymelevelsandreduceliverfatdepositioninpatientswithNAFLD.Thiseffectismorepronouncedinpatientswhoachieveaweightlossof10%ormore.

Moreover,increasingphysicalactivitycanalsocontributetothemanagementofNAFLD.Regularexercisehasbeenshowntoreduceliverfat,inflammation,andfibrosis,independentofweightloss.InpatientswithNAFLD,moderate-intensityexercise,suchasbriskwalkingorcycling,foratleast150minutesperweekisrecommended.

Furthermore,ahealthydietisanessentialcomponentofmanagingNAFLD.Adietrichinfruits,vegetables,whole-grains,andleanproteinhasbeenassociatedwithareducedriskofdevelopingNAFLDandimprovingliverfunction.Incontrast,adiethighinsaturatedfats,refinedcarbohydrates,andaddedsugarshasbeenlinkedtoanincreasedriskofNAFLDandworseningliverfunction.

Finally,avoidingalcoholconsumptioniscriticalinmanagingNAFLD.AlcoholconsumptionhasbeenshowntoincreasetheriskofdevelopingNAFLDandworsenliverdamageinpatientswithexistingNAFLD.PatientswithNAFLDshouldavoidalcoholconsumptionaltogetherorlimitittoonedrinkperdayforwomenandtwodrinksperdayformen.

Inconclusion,lifestylemodifications,includingweightloss,physicalactivity,healthydiet,andavoidingalcoholconsumption,playacrucialroleinmanagingNAFLD.Itisessentialtocombinetheselifestylemodificationswithappropriatemedicaltreatment,suchastheTCMapproachdiscussedabove,toachieveoptimalmanagementofthedisease.EducationandcounselingregardinglifestylemodificationsarethereforeessentialinthemanagementofNAFLD,andhealthcareprovidersshouldencourageandsupporttheirpatientstomakehealthylifestylechoicesAdditionally,regularmonitoringandfollow-upwithhealthcareprovidersiscrucialinthemanagementofNAFLD.PatientswithNAFLDshouldreceiveregularliverfunctiontestsandimagingstudiestomonitortheprogressofthediseaseandanypotentialcomplications.Patientsshouldalsobescreenedforothercomorbidities,suchasdiabetesandhypertension,astheseconditionscanworsentheprogressionofNAFLD.

Inconclusion,NAFLDisaprevalentandgrowing

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论